143 results on '"Marazzato, Massimiliano"'
Search Results
2. Women Skin Microbiota Modifications during Pregnancy
3. Contributors
4. Evidence on the risks and safety of probiotics for humans
5. Chronic intestinal pseudo-obstruction: associations with gut microbiota and genes expression of intestinal serotonergic pathway
6. Escherichia coli strains of chicken and human origin: Characterization of antibiotic and heavy-metal resistance profiles, phylogenetic grouping, and presence of virulence genetic markers
7. Satureja montana L. essential oil and its antimicrobial activity alone or in combination with gentamicin
8. SLAB51 Multi-Strain Probiotic Formula Increases Oxygenation in Oxygen-Treated Preterm Infants
9. Genetic diversity, phylogroup distribution and virulence gene profile of pks positive Escherichia coli colonizing human intestinal polyps
10. Atopic dermatitis-derived Staphylococcus aureus strains: what makes them special in the interplay with the host
11. Poliprotect vs Omeprazole in the Relief of Heartburn, Epigastric Pain, and Burning in Patients Without Erosive Esophagitis and Gastroduodenal Lesions: A Randomized, Controlled Trial
12. Efficacy of Pidotimod use in treating allergic rhinitis in a pediatric population
13. Poliprotect vs Omeprazole in the relief of heartburn, epigastric pain and burning in patients without erosive esophagitis and gastro-duodenal lesions: A Randomized, Controlled Trial
14. Exploiting Bacteria for Improving Hypoxemia of COVID-19 Patients
15. Gut Microbiota Structure and Metabolites, Before and After Treatment in Early Rheumatoid Arthritis Patients: A Pilot Study
16. The effect of probiotic administration on metabolomics and glucose metabolism in CF patients
17. Su1635 PATIENTS WITH NONEROSIVE HEARTBURN AND EPIGATRIC PAIN SYNDROME (EPS) ARE NOT CLINICALLY DISTINGUISHABLE AND BENEFIT OF THE SAME TREATMENT. RCT POST HOC ANALYSIS DATA
18. Mo1318 THE MUCOSAL PROTECTIVE AGENT POLIPROTECT IS AN EFFECTIVE TREATMENT TO MANAGE PPI DE-PRESCRIBING. IN NON-EROSIVE HEARTBURN AND EPIGASTRIC PAIN SYNDROME PATIENTS. RCT POST HOC ANALYSIS DATA
19. Chapter10 - Evidence on the risks and safety of probiotics for humans
20. Genetic Diversity of Antimicrobial Resistance and Key Virulence Features in Two Extensively Drug-Resistant Acinetobacter baumannii Isolates
21. Extraintestinal Pathogenic Escherichia coli: Beta-Lactam Antibiotic and Heavy Metal Resistance
22. Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients
23. Allergic rhinitis, microbiota and passive smoke in children: A pilot study
24. Lactoferrin differently modulates the inflammatory response in epithelial models mimicking human inflammatory and infectious diseases
25. Chronic Intestinal Pseudo-Obstruction: Is There a Connection with Gut Microbiota?
26. Oxygen Sparing Effect of Bacteriotherapy in COVID-19
27. Resveratrol-Loaded Nanoemulsions: In Vitro Activity on Human T24 Bladder Cancer Cells
28. Fr577 ORAL BACTERIOTHERAPY IN THE MANAGEMENTE OF FATIGUE IN COVID-19 PATIENTS
29. Fr576 ORAL BACTERIOTHERAPY IN PATIENTS WITH COVID-19: A RETROSPECTIVE COHORT STUDY
30. Dysbiosis in SARS-CoV-2–Infected Patients
31. Nanoemulsions of Satureja montana Essential Oil: Antimicrobial and Antibiofilm Activity against Avian Escherichia coli Strains
32. Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study
33. Les probiotiques jouent-ils un rôle dans les infections virales, notamment le SRAS-CoV-2 ?
34. 16S Metagenomics Reveals Dysbiosis of Nasal Core Microbiota in Children With Chronic Nasal Inflammation: Role of Adenoid Hypertrophy and Allergic Rhinitis
35. Insight into the Possible Use of the Predator Bdellovibrio bacteriovorus as a Probiotic
36. Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19
37. Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review
38. Nasal Microbiota in RSV Bronchiolitis
39. Bovine Lactoferrin Pre-Treatment Induces Intracellular Killing of AIEC LF82 and Reduces Bacteria-Induced DNA Damage in Differentiated Human Enterocytes
40. Characterization of the Ear Canal Bacterial Flora Present in Hearing Aids (HA) Wearing Subjects
41. Virulence behavior of uropathogenicEscherichia colistrains in the host modelCaenorhabditis elegans
42. Co-occurrence between multiple antibiotic resistance and heavymetal tolerance among Escherichia coli strains of avian and human origin in a catchment area of Lazio region, Italy
43. Coriander (Coriandrum sativum) Essential Oil: Effect on Multidrug Resistant UropathogenicEscherichia coli
44. The Shigella flexneri OmpA amino acid residues 188 EVQ 190 are essential for the interaction with the virulence factor PhoN2
45. Molecular characterisation of extensively drug-resistant Acinetobacter baumannii: First report of a new sequence type in Italy
46. The Adherent/Invasive Escherichia coli Strain LF82 Invades and Persists in Human Prostate Cell Line RWPE-1, Activating a Strong Inflammatory Response
47. Virulence of uropathogenic Escherichia coli strains in the host model Caenorhabditis elegans
48. When asthma and rhinitis coexist, could rhinitis reduce asthma control in children?
49. Influenza A Virus Infection of Intestinal Epithelial Cells Enhances the Adhesion Ability of Crohn’s Disease Associated Escherichia coli Strains
50. Adherent-invasive Escherichia coli (AIEC) in pediatric Crohn’s disease patients: phenotypic and genetic pathogenic features
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.